Related Experiment Video
Updated: Jul 15, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Ethical and design issues of phase I clinical trials in cancer patients
1Division of Hematology-Oncology, Cancer Center, Mount Sinai Services at Queens Hospital Center, Jamaica, New York, USA. hans.grunwald@mssm.edu
Abstract:
Therapeutic clinical trials are an absolute necessity to enhance the therapy of serious illnesses, and Phase I trials are the only way to introduce new therapeutic modalities into use in human beings. However, since the first obligation a physician has is to the individual patient's well-being and avoidance of doing harm, offering such patients an unproven therapy with low probability of benefit to him/herself and significant potential toxicities poses major ethical problems. These ethical problems can only be solved by full disclosure of all facts to the patient, a detailed explanation that the primary goal of the trial is to improve medical care (altruistic motivation), and by making sure that in addition to the trial mandated treatment the patient receives optimal palliative care, including hospice care when needed.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Bioavailability Study Design: Healthy Subjects Versus Patients
Ethical Issues
Ethical Concerns in Healthcare:
Preclinical Development: Overview
